KarinCA There are 22,000 new cases of OC every year. We are only looking for 10 patients. There has to be a reason they(IPIX and BP) picked marycrowley and I'm sure it wasn't for their slow enrollment of OC patients.
Do you know something we all don't know?
"Being a tough one to enroll, this one may fall behind schedule."
As I am sure you know Karen statements that can provide fodder for those who wish to manipulate a stock on a message board are looked for thoroughly by such imo....can you please explain further your statement cocerning the following
Certainly a benefit to having 3 drugs in active clinical trials, is that everyone can pick their own favorite. For me, it's comforting to know that we only need one success to see a significant return on investment. If we get 3 successful drugs, that will be.... (fill in with your own favorite adjectives).